Sales Of Drug-Spiked Rhino Supplements Trouble FDA After Importer's Arrest
This article was originally published in The Rose Sheet
Executive Summary
FDA's consumer warning about "Rhino" brand male enhancement products "due to a recent rise in reported health issues" marks latest detected use of ED ingredients in products fraudulently labeled as supplements and latest example of businesses flouting s regulatory framework that allows sales of most supplements without any pre-market approval process. FDA also uses announcement to recommend consumers ask for a health care provider's advice before "using or considering using any product marketed as a dietary supplement."